IIM
ANAB icon

INTECH Investment Management’s AnaptysBio ANAB Stock Holding History

INTECH Investment Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$364K Buy
5,397
+311
+6% +$18.9K ﹤0.01% 1482
2026
Q1 		$282K Sell
5,086
-1,836
-27% -$98.8K ﹤0.01% 1590
2025
Q4 		$336K Sell
6,922
-883
-11% -$34.4K ﹤0.01% 1709
2025
Q3 		$239K Sell
7,805
-2,990
-28% -$68.6K ﹤0.01% 1957
2025
Q2 		$240K Buy
+10,795
New +$226K ﹤0.01% 1997
2024
Q4 		– Sell
-6,823
Closed -$229K – 2380
2024
Q3 		$229K Buy
+6,823
New +$233K ﹤0.01% 1660

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

INTECH Investment Management's ANAB Position: Q2 2026 in Review

INTECH Investment Management increased its AnaptysBio (ANAB) stake by 6.1% in Q2 2026, buying an estimated $18.9K and bringing the position to 5,397 shares worth $364K. The position accounts for ﹤0.01% of the portfolio, ranked #1482.

INTECH Investment Management first reported a position in ANAB in Q3 2024 and has held it in 6 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • INTECH Investment Management held 5,397 shares of AnaptysBio worth $364K as of Q2 2026.
  • INTECH Investment Management bought 311 AnaptysBio shares in Q2 2026, an estimated $18.9K.
  • AnaptysBio made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1482 holding.
  • INTECH Investment Management first reported a position in AnaptysBio in Q3 2024 and has held it in 6 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.